drugset
drugset / Trial / NCT00780455

Rehabilitation Study in MS Patients

NCT00780455 ↗

Phase 4 Terminated 4 enrolled Bayer
RandomizedParallel-groupOpen-labelTreatment

Summary

Studying the effectiveness of a functional rehabilitation protocol (FRP) in early Relapsing Remitting Multiple Sclerosis (RRMS) patients treated with Betaferon by comparing the physical ability of patients with and without FRP.

Timeline

Start
2008-10
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Background Interferon beta-1b Protein / enzyme biologic 250 ug Subcutaneous

Indications

relapsing-remitting multiple sclerosis